<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02721017</url>
  </required_header>
  <id_info>
    <org_study_id>15-18202</org_study_id>
    <secondary_id>1R03HD090617-01</secondary_id>
    <secondary_id>1P50FD006424-01</secondary_id>
    <nct_id>NCT02721017</nct_id>
  </id_info>
  <brief_title>Cryoanalgesia vs. Epidural in the Nuss Procedure</brief_title>
  <official_title>Pain Control in the Nuss Procedure: A Prospective, Randomized Trial of Cryoanalgesia vs. Thoracic Epidural</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Food and Drug Administration (FDA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether cryoanalgesia provides better pain control&#xD;
      for minimally invasive pectus excavatum repair (the Nuss procedure) than thoracic epidural.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain control is a major challenge for physicians, who must ensure appropriate and effective&#xD;
      pain control for their patients, while remaining mindful of the many negative effects of&#xD;
      opioid dependence and addiction. Nowhere is there a more pressing need than in children and&#xD;
      young adults, who are at high risk for drug abuse, and in post-operative care, since&#xD;
      post-operative opioid use can be a starting point for long-term pain issues. Postoperative&#xD;
      pain control in the Nuss procedure, minimally invasive repair of the congenital chest wall&#xD;
      deformity known as pectus excavatum, remains a significant problem for the 3000 patients who&#xD;
      undergo this procedure each year, mostly adolescents and young adults. Many multimodal&#xD;
      analgesic regimens have been tried, but optimal treatment remains unknown.&#xD;
&#xD;
      This study will test a novel and promising strategy of using intra-operative cryoanalgesia&#xD;
      during the Nuss procedure. Cryoanalgesia is the localized, temporary freezing of peripheral&#xD;
      nerves, which is performed at the time of the Nuss procedure. The study is a 20-subject&#xD;
      prospective, randomized pilot trial comparing cryoanalgesia to thoracic epidural analgesia&#xD;
      for post-operative pain control in patients undergoing the Nuss procedure. Subjects will be&#xD;
      recruited from patients already scheduled for a Nuss procedure at our institution, and will&#xD;
      undergo 1:1 randomization to either cryoanalgesia or thoracic epidural analgesia for&#xD;
      perioperative pain control. During their hospitalization, patients' opiate usage will be&#xD;
      prospectively recorded, and pain will be assessed twice per day. Upon discharge, patients&#xD;
      will maintain a log of their opiate use, and will return to clinic at 2 weeks, 1 month, 3&#xD;
      months, and 1 year after Nuss procedure for post-operative assessment. Primary outcome is&#xD;
      length of perioperative hospitalization, an objective measure that synthesizes many different&#xD;
      aspects of a procedure and its subsequent post-operative course, including pain control.&#xD;
      Secondary outcomes are post-operative narcotic usage and direct cost of perioperative&#xD;
      hospitalization. Side effects of both interventions will also be assessed.&#xD;
&#xD;
      This will be the first systematic investigation of cryoanalgesia for local nerve block in a&#xD;
      thoracoscopic procedure, and the first study involving its use in adolescents and young&#xD;
      adults. The results will have direct application for those undergoing the Nuss procedure to&#xD;
      repair pectus excavatum. Investigators will also delineate a reproducible protocol for&#xD;
      delivering cryoanalgesia thoracoscopically, to ensure others can safely and effectively use&#xD;
      this method if it proves beneficial. Although the focus is on the small subset of patients&#xD;
      who undergo the Nuss procedure, if a standardized approach to cryoanalgesia delivery in a&#xD;
      thoracoscopic procedure has a positive effect on patient outcomes and cost of&#xD;
      hospitalization, the technique could be applied to a variety of surgical procedures, as well&#xD;
      as for other neuropathic pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Actual">September 2018</completion_date>
  <primary_completion_date type="Actual">August 28, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of Hospitalization</measure>
    <time_frame>estimated one week or less</time_frame>
    <description>the length of the patient's in-hospital stay following admission for Nuss procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Narcotic Usage</measure>
    <time_frame>Post Operative Hospital Stay</time_frame>
    <description>Inpatient narcotic usage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Neuropathic Pain Score at One Year</measure>
    <time_frame>one year</time_frame>
    <description>Neuropathic specific pain (described as &quot;burning&quot;, &quot;electrical&quot; or &quot;tingling&quot; sensations) was assessed by study questionnaire via numerical pain scale (1 to 10, with 10 representing a maximum score, or worst pain possible).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost Analysis</measure>
    <time_frame>estimated one week</time_frame>
    <description>cost analysis of initial hospitalization following Nuss procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Pectus Excavatum</condition>
  <condition>Funnel Chest</condition>
  <arm_group>
    <arm_group_label>Cryoanalgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thoracic Epidural</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracic epidural (ropivicaine, fentanyl).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryoanalgesia</intervention_name>
    <arm_group_label>Cryoanalgesia</arm_group_label>
    <other_name>AtriCure</other_name>
    <other_name>cryoprobe</other_name>
    <other_name>nerve freezing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thoracic epidural (ropivicaine, fentanyl)</intervention_name>
    <description>Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.</description>
    <arm_group_label>Thoracic Epidural</arm_group_label>
    <other_name>Epidural</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  scheduled for Nuss procedure for pectus excavatum correction&#xD;
&#xD;
          -  at least 13 years old at the time of the procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age less than 13 years at time of procedure&#xD;
&#xD;
          -  use of pain medication prior to procedure&#xD;
&#xD;
          -  pectus carinatum, Poland's syndrome, or any chest wall anomaly other than pectus&#xD;
             excavatum&#xD;
&#xD;
          -  previous repair of pectus excavatum by any technique&#xD;
&#xD;
          -  previous thoracic surgery&#xD;
&#xD;
          -  congenital heart disease&#xD;
&#xD;
          -  bleeding dyscrasia&#xD;
&#xD;
          -  major anesthetic risk factors or history of previous problem with anesthesia&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  inability to communicate in English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Padilla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>415-370-2835</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF-Benioff Children's Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Graves C, Idowu O, Lee S, Padilla B, Kim S. Intraoperative cryoanalgesia for managing pain after the Nuss procedure. J Pediatr Surg. 2017 Jun;52(6):920-924. doi: 10.1016/j.jpedsurg.2017.03.006. Epub 2017 Mar 16.</citation>
    <PMID>28341230</PMID>
  </reference>
  <results_reference>
    <citation>Graves CE, Moyer J, Zobel MJ, Mora R, Smith D, O'Day M, Padilla BE. Intraoperative intercostal nerve cryoablation During the Nuss procedure reduces length of stay and opioid requirement: A randomized clinical trial. J Pediatr Surg. 2019 Nov;54(11):2250-2256. doi: 10.1016/j.jpedsurg.2019.02.057. Epub 2019 Mar 17.</citation>
    <PMID>30935731</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2016</study_first_posted>
  <results_first_submitted>August 27, 2019</results_first_submitted>
  <results_first_submitted_qc>May 3, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 5, 2021</results_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nuss</keyword>
  <keyword>Nuss Procedure</keyword>
  <keyword>pectus excavatum</keyword>
  <keyword>cryoanalgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Funnel Chest</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 7, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT02721017/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Twenty consecutive patients were recruited from those scheduled for the Nuss procedure.</recruitment_details>
      <pre_assignment_details>Exclusion criteria were age &lt;13 years, chest wall anomaly other than pectus excavatum, previous repair or other thoracic surgery, and chronic use of pain medications.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cryoanalgesia</title>
          <description>Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure&#xD;
Cryoanalgesia</description>
        </group>
        <group group_id="P2">
          <title>Thoracic Epidural</title>
          <description>Thoracic epidural (ropivicaine, fentanyl).&#xD;
Thoracic epidural (ropivicaine, fentanyl): Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Hospital Stay</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10">Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).</participants>
                <participants group_id="P2" count="10">Thoracic Epidural placed on Date of Surgery (DOS).</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10">Completed during the course of surgery.</participants>
                <participants group_id="P2" count="10">Removal occurs prior to Hospital Discharge.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Participant Follow Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10">Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.</participants>
                <participants group_id="P2" count="10">Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10">12 months after Date of Surgery.</participants>
                <participants group_id="P2" count="10">12 months after Date of Surgery.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cryoanalgesia</title>
          <description>Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure&#xD;
Cryoanalgesia</description>
        </group>
        <group group_id="B2">
          <title>Thoracic Epidural</title>
          <description>Thoracic epidural (ropivicaine, fentanyl).&#xD;
Thoracic epidural (ropivicaine, fentanyl): Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.9" lower_limit="14" upper_limit="31"/>
                    <measurement group_id="B2" value="16.1" lower_limit="13" upper_limit="21"/>
                    <measurement group_id="B3" value="18.5" lower_limit="13" upper_limit="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Length of Hospitalization</title>
        <description>the length of the patient's in-hospital stay following admission for Nuss procedure</description>
        <time_frame>estimated one week or less</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cryoanalgesia</title>
            <description>Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure.</description>
          </group>
          <group group_id="O2">
            <title>Thoracic Epidural</title>
            <description>Thoracic epidural (ropivicaine, fentanyl).&#xD;
Thoracic epidural (ropivicaine, fentanyl): Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospitalization</title>
          <description>the length of the patient's in-hospital stay following admission for Nuss procedure</description>
          <units>Length of Stay (Post-Operative Days)</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="O2" value="5" lower_limit="4" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Narcotic Usage</title>
        <description>Inpatient narcotic usage</description>
        <time_frame>Post Operative Hospital Stay</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cryoanalgesia</title>
            <description>Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure&#xD;
Cryoanalgesia</description>
          </group>
          <group group_id="O2">
            <title>Thoracic Epidural</title>
            <description>Thoracic epidural (ropivicaine, fentanyl).&#xD;
Thoracic epidural (ropivicaine, fentanyl): Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.</description>
          </group>
        </group_list>
        <measure>
          <title>Narcotic Usage</title>
          <description>Inpatient narcotic usage</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="268" spread="165.2"/>
                    <measurement group_id="O2" value="684" spread="191.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Neuropathic Pain Score at One Year</title>
        <description>Neuropathic specific pain (described as &quot;burning&quot;, &quot;electrical&quot; or &quot;tingling&quot; sensations) was assessed by study questionnaire via numerical pain scale (1 to 10, with 10 representing a maximum score, or worst pain possible).</description>
        <time_frame>one year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cryoanalgesia</title>
            <description>Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure</description>
          </group>
          <group group_id="O2">
            <title>Thoracic Epidural</title>
            <description>Thoracic epidural (ropivicaine, fentanyl).&#xD;
Thoracic epidural (ropivicaine, fentanyl): Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Neuropathic Pain Score at One Year</title>
          <description>Neuropathic specific pain (described as &quot;burning&quot;, &quot;electrical&quot; or &quot;tingling&quot; sensations) was assessed by study questionnaire via numerical pain scale (1 to 10, with 10 representing a maximum score, or worst pain possible).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="2.69"/>
                    <measurement group_id="O2" value="1.9" spread="1.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost Analysis</title>
        <description>cost analysis of initial hospitalization following Nuss procedure</description>
        <time_frame>estimated one week</time_frame>
        <population>Cost analysis was not performed, as these data were not collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Cryoanalgesia</title>
            <description>Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure.</description>
          </group>
          <group group_id="O2">
            <title>Thoracic Epidural</title>
            <description>Thoracic epidural (ropivicaine, fentanyl).&#xD;
Thoracic epidural (ropivicaine, fentanyl): Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.</description>
          </group>
        </group_list>
        <measure>
          <title>Cost Analysis</title>
          <description>cost analysis of initial hospitalization following Nuss procedure</description>
          <population>Cost analysis was not performed, as these data were not collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All adverse events reported post operatively at the 2 week, 1 month, 3 month and 1 year follow up points were collected. In addition all serious adverse events that occurred following enrollment were as well collected. The collection period for all serious adverse events began after informed consent was obtained and ended after procedures for the final study visit had been completed at the 1 year post-operative mark.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cryoanalgesia</title>
          <description>Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure&#xD;
Cryoanalgesia</description>
        </group>
        <group group_id="E2">
          <title>Thoracic Epidural</title>
          <description>Thoracic epidural (ropivicaine, fentanyl).&#xD;
Thoracic epidural (ropivicaine, fentanyl): Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Infection from indwelling thoracic epidural catheter</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Paraplegia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Symptomatic Pneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Benjamin Padilla</name_or_title>
      <organization>University of California San Francisco Department of Surgery</organization>
      <phone>415-476-3642</phone>
      <email>Benjamin.Padilla@ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

